China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.88 -0.22 (-7.10%)
At close: Nov 10, 2026 · 4:00 PM EST

China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2020)

Updated

China SXT Pharmaceuticals' Current Deferred Tax Assets was $50,000 in fiscal Q4 2020 (quarter ended Mar 31, 2020).

Analysis

China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 China SXT Pharmaceuticals 251.61 -85.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2020 50,000.00
API Access

China SXT Pharmaceuticals Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=SXTC&period=max&api_key=YOUR_API_KEY